General Information
Drug ID
DR00275
Drug Name
Bestatin
Synonyms
((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-D-leucine; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid; (2R)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid; AC1L972Z; AKOS026750073; BDBM50010142; Bestatin (TN); C00732; CHEBI:140702; CHEBI:3070; CHEMBL476869; D00087; DTXSID4048430; GTPL5151; NCGC00161660-01; SCHEMBL25971; SureCN25971; UPCMLD-DP116; UPCMLD-DP116:001; Ubenimex (JP16/INN); Ubenimex (JP17/INN); ZINC01532730; ZINC1532730
Drug Type
Small molecular drug
Indication Acute myeloid leukemia [ICD11: 2A60] Approved [1]
Structure
3D MOL 2D MOL
Formula
C16H24N2O4
Canonical SMILES
CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O
InChI
InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13-,14+/m1/s1
InChIKey
VGGGPCQERPFHOB-MCIONIFRSA-N
CAS Number
CAS 58970-76-6
Pharmaceutical Properties Molecular Weight 308.37 Topological Polar Surface Area 113
Heavy Atom Count 22 Rotatable Bond Count 8
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 5
XLogP
-1
PubChem CID
439299
PubChem SID
104114258 , 104620159 , 135751514 , 137009976 , 160966547 , 178101843 , 179315977 , 223439098 , 22391527 , 226413937 , 242057541 , 242084743 , 252216542 , 26755319 , 36883546 , 3996 , 46488031 , 46505598 , 50818560 , 57402961 , 7847155
ChEBI ID
CHEBI:3070
TTD Drug ID
D0RA5Q
DT(s) Transporting This Drug PEPT1 Transporter Info Peptide transporter 1 Substrate [2]
PEPT2 Transporter Info Peptide transporter 2 Substrate [3]
Drug-Transporter Activity Data
Drug-Transporter Activity Data PEPT1 Transporter Info Km = 340 microM Human enterocyte-like 2 cells (Caco-2)-PEPT1 [2]
References
1 Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival. Gan To Kagaku Ryoho. 2003 Aug;30(8):1113-8.
2 Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am J Physiol. 1993 Aug;265(2 Pt 1):G289-94.
3 Molecular mechanism of dipeptide and drug transport by the human renal H+/oligopeptide cotransporter hPEPT2. Am J Physiol Renal Physiol. 2008 Jun;294(6):F1422-32.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.